SCHEMBL1674832

SCHEMBL1674832

CC[C@@H](c1ccccc1)N(Cc1cccc(C(=O)O)c1)S(=O)(=O)c1ccc(Cl)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 1/20 0.57
PSEN2 P49810 1/20 0.57
APH1B Q8WW43 1/20 0.57
NCSTN Q92542 1/20 0.57
APH1A Q96BI3 1/20 0.57
PSENEN Q9NZ42 1/20 0.57
MEN1 O00255 5/20 0.51
KMT2A Q03164 5/20 0.51
TAS2R14 Q9NYV8 6/20 0.50
CXCR3 P49682 1/20 0.50
POLB P06746 1/20 0.46
MEP1B Q16820 5/20 0.45
GAA P10253 1/20 0.45
TP53 P04637 1/20 0.44
MEP1A Q16819 2/20 0.44
DAGLA Q9Y4D2 1/20 0.44
ADAM10 O14672 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
MMP13 P45452 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15388332 1.00 PSEN1 (0.57) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15388038 0.90 MAPT (0.48) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15387962 0.88 PSEN1 (0.73) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL1674844 0.88 PSEN1 (0.73) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15388044 0.84 CXCR3 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15387950 0.84 PSEN1 (0.55) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL10206401 0.84 CXCR3 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL15396115 0.84 PSEN1 (0.77) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5115958 0.83 MEN1 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5115947 0.83 MEN1 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130310384-A1 Sulfonamide-Containing Compounds THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2013-11-21 US disclosed
US-20130310384-A1 Sulfonamide-Containing Compounds THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2013-11-21 US disclosed
WO-2012047926-A2 SULFONAMIDE-CONTAINING COMPOUNDS THE BRIGHAM AND WOMEN'S HOSPITAL, INC. (US) 2012-04-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130310384-A1 Sulfonamide-Containing Compounds BACE1, BACE2, GSAP PSEN1 4/4885PSEN2 5/4885APH1B 8/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.